These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

209 related items for PubMed ID: 3085137

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Adinazolam, diazepam, imipramine, and placebo in major depressive disorder: a controlled study.
    Rickels K, London J, Fox I, Hassman H, Csanalosi I, Weise C.
    Pharmacopsychiatry; 1991 Jul; 24(4):127-31. PubMed ID: 1754608
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Double-blind efficacy and safety study comparing adinazolam mesylate and placebo in depressed inpatients.
    Smith WT, Glaudin V.
    Acta Psychiatr Scand; 1986 Sep; 74(3):238-45. PubMed ID: 3538786
    [Abstract] [Full Text] [Related]

  • 5. A review of controlled studies of adinazolam mesylate in patients with major depressive disorder.
    Feighner JP.
    Psychopharmacol Bull; 1986 Sep; 22(1):186-91. PubMed ID: 3523576
    [No Abstract] [Full Text] [Related]

  • 6. A comparison of adinazolam and desipramine in the treatment of major depression.
    Kennedy SH, de Groot J, Ralevski E, Reed K.
    Int Clin Psychopharmacol; 1991 Sep; 6(2):65-76. PubMed ID: 1960382
    [Abstract] [Full Text] [Related]

  • 7. Comparison of adinazolam, amitriptyline, and placebo in the treatment of melancholic depression.
    Hicks F, Robins E, Murphy GE.
    Psychiatry Res; 1988 Feb; 23(2):221-7. PubMed ID: 3283804
    [Abstract] [Full Text] [Related]

  • 8. Comparison of adinazolam, amitriptyline, and diazepam in endogenous depressive inpatients exhibiting DST nonsuppression or abnormal contingent negative variation.
    Ansseau M, Devoitille JM, Papart P, Vanbrabant E, Mantanus H, Timsit-Berthier M.
    J Clin Psychopharmacol; 1991 Jun; 11(3):160-5. PubMed ID: 2066454
    [Abstract] [Full Text] [Related]

  • 9. Alprazolam: a review of its pharmacodynamic properties and efficacy in the treatment of anxiety and depression.
    Dawson GW, Jue SG, Brogden RN.
    Drugs; 1984 Feb; 27(2):132-47. PubMed ID: 6141930
    [Abstract] [Full Text] [Related]

  • 10. A double-blind comparison of alprazolam vs. imipramine and placebo in the treatment of major depressive disorder.
    Feighner JP, Meredith CH, Frost NR, Chammas S, Hendrickson G.
    Acta Psychiatr Scand; 1983 Oct; 68(4):223-33. PubMed ID: 6138925
    [Abstract] [Full Text] [Related]

  • 11. Double-blind comparison of alprazolam versus imipramine in the inpatient treatment of major depressive illness.
    Lenox RH, Shipley JE, Peyser JM, Williams JM, Weaver LA.
    Psychopharmacol Bull; 1984 Oct; 20(1):79-82. PubMed ID: 6144136
    [No Abstract] [Full Text] [Related]

  • 12. Rolipram in major depressive disorder: results of a double-blind comparative study with imipramine.
    Hebenstreit GF, Fellerer K, Fichte K, Fischer G, Geyer N, Meya U, Sastre-y-Hernández M, Schöny W, Schratzer M, Soukop W.
    Pharmacopsychiatry; 1989 Jul; 22(4):156-60. PubMed ID: 2668980
    [Abstract] [Full Text] [Related]

  • 13. Minaprine and imipramine in the treatment of major depressive disorders. A comparative double-blind study.
    Bohacek N, Ravic M, Bizière K.
    Drugs Exp Clin Res; 1987 Jul; 13(7):435-42. PubMed ID: 3308390
    [Abstract] [Full Text] [Related]

  • 14. A fixed-dose study of adinazolam-SR tablets in generalized anxiety disorder.
    Wilcox CS, Ryan PJ, Morrissey JL, Cohn JB, DeFrancisco DF, Linden RD, Heiser JF.
    Prog Neuropsychopharmacol Biol Psychiatry; 1994 Oct; 18(6):979-93. PubMed ID: 7824763
    [Abstract] [Full Text] [Related]

  • 15. Adinazolam mesylate and placebo in depressed outpatients: a 6-week, double-blind comparison.
    Cohn JB, Pyke RE, Wilcox CS.
    J Clin Psychiatry; 1988 Apr; 49(4):142-7. PubMed ID: 3281930
    [Abstract] [Full Text] [Related]

  • 16. Comparative efficacy of alprazolam, imipramine, and placebo administered once a day in treating depressed patients.
    Mendels J, Schless AP.
    J Clin Psychiatry; 1986 Jul; 47(7):357-61. PubMed ID: 2873131
    [Abstract] [Full Text] [Related]

  • 17. A controlled trial of adinazolam versus desipramine in geriatric depression.
    Feighner JP, Boyer WF, Hendrickson GG, Pambakian RA, Doroski VS.
    Int Clin Psychopharmacol; 1990 Jul; 5(3):227-32. PubMed ID: 2230067
    [Abstract] [Full Text] [Related]

  • 18. Double-blind comparison of alprazolam and adinazolam for panic and phobic disorders.
    Pyke RE, Greenberg HS.
    J Clin Psychopharmacol; 1989 Feb; 9(1):15-21. PubMed ID: 2651489
    [Abstract] [Full Text] [Related]

  • 19. A double-blind clinical trial of fluvoxamine and imipramine in patients with primary depression.
    Guy W, Wilson WH, Ban TA, King DL, Manov G, Fjetland OK.
    Psychopharmacol Bull; 1984 Feb; 20(1):73-8. PubMed ID: 6425916
    [No Abstract] [Full Text] [Related]

  • 20. Efficacy and tolerance of femoxetine and imipramine in the treatment of depressive states. A randomized, double-blind study.
    Suominen J, Tamminen T, Elosuo R, Manniche PM.
    Pharmacopsychiatry; 1988 Sep; 21(5):238-44. PubMed ID: 3067246
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.